Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA Takes “Fresh Look” At ORA Reorg, Eyes Outsourcing Some Agency Posts

Executive Summary

FDA's decision to cancel the planned closure of seven field labs does not signal the end of efforts to reorganize the Office of Regulatory Affairs

You may also be interested in...



FDA Office of Regulatory Affairs Make-Over Blends Domestic, International Work

The reorganized ORA has eight new offices to better handle new legislative authorities and globalization of its regulated products; FDA expects to increase partnerships with other government officials and foreign entities.

New Faces Will Lead Office Of Regulatory Affairs As Two Top Officials Depart

The face of FDA's Office of Regulatory Affairs will undergo a major change as two senior leaders leave the office responsible for managing inspections and enforcement activity

New Faces Will Lead Office Of Regulatory Affairs As Two Top Officials Depart

The face of FDA's Office of Regulatory Affairs will undergo a major change as two senior leaders leave the office responsible for managing inspections and enforcement activity

Related Content

UsernamePublicRestriction

Register

LL1135645

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel